Are Agribio Spirits Ltd latest results good or bad?

1 hour ago
share
Share Via
Agribio Spirits Ltd's latest results show strong revenue growth of 65.39% quarter-on-quarter and 174.95% year-on-year, but a decline in net profit by 18.18% and ongoing negative operating margins indicate significant operational challenges. While historical returns are impressive, concerns about sustainability and reliance on non-operating income persist.
Agribio Spirits Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant revenue growth but persistent operational challenges. The company reported consolidated net sales of ₹12.95 crores, reflecting a substantial increase of 65.39% quarter-on-quarter and an impressive 174.95% year-on-year. This surge in sales indicates successful market penetration and trading activities. However, the consolidated net profit for the same quarter was ₹0.90 crores, which represents a decline of 18.18% compared to the previous quarter, highlighting a troubling trend in profitability.
The operating margin, excluding other income, remained negative at -0.93%, indicating that the company continues to face difficulties in converting its revenue into operational profit. This negative margin has been a recurring issue, with the company reporting negative operating margins in five of the last seven quarters. Furthermore, the return on equity stands at 8.84%, which is below average, suggesting inefficiencies in capital utilization. While Agribio Spirits has demonstrated remarkable historical returns, including a five-year growth of 5,155.71%, the recent performance raises concerns about the sustainability of such growth. The company's reliance on non-operating income to achieve profitability further complicates its financial narrative, as core operations have not generated adequate returns. Overall, Agribio Spirits Ltd's financial results illustrate a company experiencing robust sales growth amidst significant operational weaknesses. The company saw an adjustment in its evaluation, reflecting these underlying challenges and the disconnect between its market performance and fundamental business health.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News